Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN OPEN LABEL, SINGLE ARM TRIAL OF IMMUNOTHERAPY WITH AUTOLOGOUS ANTIGEN PRESENTING CELLS LOADED WITH PA2024 (APC8015F) FOR MEN WITH OBJECTIVE DISEASE PROGRESSION ON PROTOCOL D9902 PART B

NCT00849290 is registered in ClinicalTrials.gov with Dendreon as lead sponsor.

NCT NCT00849290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00849290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN OPEN LABEL, SINGLE ARM TRIAL OF IMMUNOTHERAPY WITH AUTOLOGOUS ANTIGEN PRESENTING CELLS LOADED WITH PA2024 (APC8015F) FOR MEN WITH OBJECTIVE DISEASE PROGRESSION ON PROTOCOL D9902 PART B
Lead sponsor
Dendreon
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2009
Enrollment
113 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic androgen independent prostate cancer